Leveraging ELISA and PCR for Potency Assay Development in AAV-Related Gene Therapy to Aid Comparability

Time: 2:15 pm
day: Conference Day One


  • Exploring challenges in characterizing and analyzing AAV-related gene therapy products
  • Designing ELISA-based assays for quantifying AAV vector titers and assessing their functional activity
  • Strategies for designing PCR-based assays to validate gene expression and therapeutic payload delivery